Stock Quote

FDA expected to authorize an extra COVID-19 dose for people with weak immune systems in the first regulatory OK for a booster shot in the U.S.

The U.S. is expected to soon authorize two COVID-19 booster shots for people with compromised immune systems in a move that underscores the risk that the virus still poses to some vaccinated Americans.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.